MedKoo Cat#: 535269 | Name: Homeostan

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Homeostan is a bioactive chemical.

Chemical Structure

Homeostan
Homeostan
CAS#25614-78-2

Theoretical Analysis

MedKoo Cat#: 535269

Name: Homeostan

CAS#: 25614-78-2

Chemical Formula: C9H14N2O3

Exact Mass: 198.1004

Molecular Weight: 198.22

Elemental Analysis: C, 54.53; H, 7.12; N, 14.13; O, 24.21

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Homeostan
IUPAC/Chemical Name
2-Butenamide, N-((acetylamino)carbonyl)-2-ethyl-, (Z)- (9CI)
InChi Key
GIVGVNLRHLKCMH-DAXSKMNVSA-N
InChi Code
InChI=1S/C9H14N2O3/c1-4-7(5-2)8(13)11-9(14)10-6(3)12/h4H,5H2,1-3H3,(H2,10,11,12,13,14)/b7-4-
SMILES Code
C/C=C(CC)\C(NC(NC(C)=O)=O)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 198.22 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Lisowska KA, Bryl E. The role of vitamin D in the development of autoimmune diseases. Postepy Hig Med Dosw (Online). 2017 Aug 28;71(1):797-810. doi: 10.5604/01.3001.0010.3857. PMID: 28894040. 2: Mieszczański P, Błaszczyk B, Śmietanowska-Więtczak M, Trzebicki J. Kopeptyna – nowy biomarker zaburzeń homeostazy w okresie okołooperacyjnym [Copeptin - a novel biomarker for perioperative homeostasis disorders]. Pol Merkur Lekarski. 2019 Sep 25;47(279):114-117. Polish. PMID: 31557142. 3: Mieczkowski M, Kościelska M. Zaburzenia homeostazy magnezu: hipermagnezemia mia [Magnesium homeostasis disorders: hypermagnesemia]. Wiad Lek. 2013;66(4):317-8. Polish. PMID: 24490486. 4: Pukajło K, Kolackov K, Łaczmański Ł, Daroszewski J. Iryzyna – nowy mediator homeostazy energetycznej [Irisin--a new mediator of energy homeostasis]. Postepy Hig Med Dosw (Online). 2015 Feb 21;69:233-42. Polish. doi: 10.5604/17322693.1141097. PMID: 25720610. 5: Lipiński P, Starzyński RR, Styś A, Gajowiak A, Staroń R. Metabolizm hemu jako integralny element homeostazy żelaza [Heme metabolism as an integral part of iron homeostasis]. Postepy Hig Med Dosw (Online). 2014 Jan 2;68:557-70. Polish. doi: 10.5604/17322693.1102284. PMID: 24864106. 6: Mieczkowski M, Kościelska M. Zaburzenia homeostazy magnezu: hipomagnezemia [Magnesium homeostasis disorders: hypomagnesemia]. Wiad Lek. 2013;66(4):314-6. Polish. PMID: 24490485. 7: Lipiński P, Starzyński RR. Regulacja ogólnoustrojowej homeostazy zelaza przez hepcydyne [Regulation of body iron homeostasis by hepcidin]. Postepy Hig Med Dosw (Online). 2004 Mar 8;58:65-73. Polish. PMID: 15069380. 8: Chrościcki P, Usarek M, Bryla J. Znaczenie zegara biologicznego w utrzymaniu homeostazy glukozy [The role of biological clock in glucose homeostasis]. Postepy Hig Med Dosw (Online). 2013 Jun 20;67:569-83. Polish. doi: 10.5604/17322693.1053906. PMID: 23799401. 9: Kirsz K, Zięba DA. Odkrycie neuromedyny U i jej rola w centralnej regulacji homeostazy energetycznej [The discovery of neuromedin U and its pivotal role in the central regulation of energy homeostasis]. Postepy Hig Med Dosw (Online). 2012 Apr 16;66:196-203. Polish. doi: 10.5604/17322693.991448. PMID: 22706104. 10: Neuwirthová J, Gál B, Smilek P, Kostřica R. Význam chuti v udržení homeostázy organizmu a patologický dopad vyrušení orocefalických reflexů ve vazbě na sladkou chuť v následku konzumace nekalorických sladidel [Importance of taste in maintaining homeostasis and pathological impact of orosensory reflexes distraction in relation to sweet taste after non-caloric sweeteners consumption]. Vnitr Lek. 2014 May-Jun;60(5-6):454-7. Czech. PMID: 24974748. 11: Drzewińska J, Pułaski L, Soszyński M, Bartosz G. Seladyna 1/DHCR24: główne białko homeostazy komórkowej i biosyntezy cholesterolu [Seladin-1/DHCR24: a key protein of cell homeostasis and cholesterol biosynthesis]. Postepy Hig Med Dosw (Online). 2009 Jul 13;63:318-30. Polish. PMID: 19597241. 12: Dobrzyń P. Rola desaturazy stearoilo-CoA w utrzymaniu homeostazy metabolicznej [Stearoyl-CoA desaturase in the control of metabolic homeostasis]. Postepy Biochem. 2012;58(2):166-74. Polish. PMID: 23214140. 13: Otto Buczkowska E, Dworzecki T. Mieśnie szkieletowe i ich rola w utrzymaniu homeostazy glukozy [The role of skeletal muscle in the regulation of glucose homeostasis]. Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2003;9(2):93-7. Polish. PMID: 14575619. 14: Kiałka M, Doroszewska K, Mrozińska S, Milewicz T, Stochmal E, Krzysiek J. Wielopoziomowe zakłócenia homeostazy hormonów tarczycy spowodowane przez substancje chemiczne wystepujace w środowisku naturalnym [The disturbances of the thyroid hormone homeostasis caused by chemical substances occurring in natural environment]. Przegl Lek. 2014;71(7):403-6. Polish. PMID: 25338338. 15: Trčka F, Müller P, Vojtěšek B. Mechanizmy regulace proteinové homeostázy ve vývoji nádorových onemocnění [Mechanisms of Protein Homeostasis Regulation in Cancer Development]. Klin Onkol. 2016 Fall;29 Suppl 4(Suppl 4):18-24. Czech. PMID: 27846716. 16: Buczkowska EO. Rola nerek w utrzymaniu homeostazy glukozy [The role of the human kidney for glucose homeostasis]. Wiad Lek. 2004;57(3-4):158-60. Polish. PMID: 15307525. 17: Kvasnicka T. NO (oxid dusnatý) a jeho význam pri regulaci vaskulární homeostázy [NO (nitric oxide) and its significance in regulation of vascular homeostasis]. Vnitr Lek. 2003 Apr;49(4):291-6. Czech. PMID: 12793052. 18: Buczkowska EO, Jarosz-Chobot P. Insulina jako regulator przemian metabolicznych w mieśniach szkieletowych i rola mieśni w utrzymaniu homeostazy glukozy [Insulin effect on metabolism in skeletal muscles and the role of muscles in regulation of glucose homeostasis]. Przegl Lek. 2001;58(7-8):782-7. Polish. PMID: 11769387. 19: Kubiak-Wlekły A, Niemir ZI. Znaczenie neprylizyny w utrzymywaniu homeostazy ustroju oraz jej udział w procesach patologicznych [The relevance of neprilysin for systemic homeostasis and its involvement in the pathological processes]. Pol Merkur Lekarski. 2009 Jul;27(157):51-4. Polish. PMID: 19650431. 20: Otto Buczkowska E, Jarosz Chobot P, Szirer G. Homeostaza glukozy. Cześć II. Zaburzenia homeostazy--hipoglikemia u noworodków i niemowlat [Glucose homeostasis. II. Homeostasis disturbances--hypoglycemia in newborns and infants]. Przegl Lek. 2001;58(2):79-81. Polish. PMID: 11475848.